These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8467471)

  • 1. Involvement of 22q12 in a neurofibrosarcoma in neurofibromatosis type 1.
    Rey JA; Bello MJ; Kusak ME; de Campos JM; Pestaña A
    Cancer Genet Cytogenet; 1993 Mar; 66(1):28-32. PubMed ID: 8467471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomes 17 and 22 involved in marker formation in neurofibrosarcoma in von Recklinghausen disease. A cytogenetic and in situ hybridization study.
    Decker HJ; Cannizzaro LA; Mendez MJ; Leong SP; Bixenman H; Berger C; Sandberg AA
    Hum Genet; 1990 Aug; 85(3):337-42. PubMed ID: 2118474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic clones in a recurrent neurofibroma.
    Rey JA; Bello MJ; de Campos JM; Benítez J; Sarasa JL; Boixados JR; Sánchez Cascos A
    Cancer Genet Cytogenet; 1987 May; 26(1):157-63. PubMed ID: 3103906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple cytogenetic aberrations in neurofibrosarcomas complicating neurofibromatosis.
    Riccardi VM; Elder DW
    Cancer Genet Cytogenet; 1986 Nov; 23(3):199-209. PubMed ID: 3094930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losses in chromosomes 17, 19, and 22q in neurofibromatosis type 1 and sporadic neurofibromas: a comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    Cancer Genet Cytogenet; 2002 Jul; 136(2):113-20. PubMed ID: 12237234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New markers for the neurofibromatosis-2 region generated by microdissection of chromosome 22.
    Fiedler W; Claussen U; Lüdecke HJ; Senger G; Horsthemke B; Geurts Van Kessel A; Goertzen W; Fahsold R
    Genomics; 1991 Jul; 10(3):786-91. PubMed ID: 1909684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches.
    Rey JA; Bello MJ; de Campos JM; Vaquero J; Kusak ME; Sarasa JL; Pestaña A
    Cancer Genet Cytogenet; 1993 Mar; 66(1):1-10. PubMed ID: 8467468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
    Legius E; Marchuk DA; Collins FS; Glover TW
    Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
    Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis.
    Seizinger BR; Rouleau G; Ozelius LJ; Lane AH; St George-Hyslop P; Huson S; Gusella JF; Martuza RL
    Science; 1987 Apr; 236(4799):317-9. PubMed ID: 3105060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-MB constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?
    Bruder CE; Ichimura K; Blennow E; Ikeuchi T; Yamaguchi T; Yuasa Y; Collins VP; Dumanski JP
    Genes Chromosomes Cancer; 1999 Jun; 25(2):184-90. PubMed ID: 10338003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on biologic behavior and surgical implications of neurofibromatosis and neurofibrosarcoma.
    Dales RL; McEver VW; Quispe G; Davies RS
    Surg Gynecol Obstet; 1983 May; 156(5):636-40. PubMed ID: 6405495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
    Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
    Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurofibroma and neurofibrosarcoma in Recklinghausen's neurofibromatosis].
    von Gumppenberg S; Karpf PM; Prokscha GW; Kramann B; Neher G
    Fortschr Med; 1978 Aug; 96(31):1563-8. PubMed ID: 97194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
    Friedman JM; Fialkow PJ; Greene CL; Weinberg MN
    J Natl Cancer Inst; 1982 Dec; 69(6):1289-92. PubMed ID: 6815362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial loss and gain of sequences on chromosome 22 in meningiomas with normal karyotype.
    Prowald A; Wemmert S; Biehl C; Storck S; Martin T; Henn W; Ketter R; Meese E; Zang KD; Steudel WI; Urbschat S
    Int J Oncol; 2005 Feb; 26(2):385-93. PubMed ID: 15645123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 90 kb DNA deletion associated with neurofibromatosis type 1.
    Upadhyaya M; Cheryson A; Broadhead W; Fryer A; Shaw DJ; Huson S; Wallace MR; Andersen LB; Marchuk DA; Viskochil D
    J Med Genet; 1990 Dec; 27(12):738-41. PubMed ID: 2127432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.